Risk factors for, and clinical relevance of, faecal extended-spectrum β-lactamase producing Escherichia coli (ESBL-EC) carriage in neutropenic patients with haematological malignancies. (Q54376284)

From Wikidata

Jump to navigation Jump to search

scientific article published on 30 October 2010

Language	Label	Description	Also known as
English	Risk factors for, and clinical relevance of, faecal extended-spectrum β-lactamase producing Escherichia coli (ESBL-EC) carriage in neutropenic patients with haematological malignancies.	scientific article published on 30 October 2010

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21052757%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Risk factors for, and clinical relevance of, faecal extended-spectrum β-lactamase producing Escherichia coli (ESBL-EC) carriage in neutropenic patients with haematological malignancies (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21052757%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference

based on heuristic

inferred from title

Escherichia coli

1 reference

based on heuristic

inferred from title

M. Angeles Domínguez

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21052757%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Jordi Carratala

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21052757%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

author name string

M Arnan

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21052757%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

C Gudiol

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21052757%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

L Calatayud

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21052757%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

J Liñares

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21052757%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

M Batlle

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21052757%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

J M Ribera

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21052757%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

F Gudiol

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21052757%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

publication date

30 October 2010

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21052757%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

European Journal of Clinical Microbiology & Infectious Diseases

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21052757%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

30

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21052757%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

355-360

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21052757%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21052757%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

https://scigraph.springernature.com/pub.10.1007/s10096-010-1093-x

0 references

Emergence of quinolone-resistant Escherichia coli bacteremia in neutropenic patients with cancer who have received prophylactic norfloxacin.

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1093-X

21 January 2018

Molecular epidemiological analysis of quinolone-resistant Escherichia coli causing bacteremia in neutropenic patients with leukemia in Korea

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1093-X

21 January 2018

Changing epidemiology of infections in patients with neutropenia and cancer: emphasis on gram-positive and resistant bacteria

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1093-X

21 January 2018

Analysis of 4758 Escherichia coli bacteraemia episodes: predictive factors for isolation of an antibiotic-resistant strain and their impact on the outcome

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1093-X

21 January 2018

Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1093-X

21 January 2018

Community infections caused by extended-spectrum beta-lactamase-producing Escherichia coli.

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1093-X

21 January 2018

Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1093-X

21 January 2018

Prospective study of fecal colonization by extended-spectrum-beta-lactamase-producing Escherichia coli in neutropenic patients with cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1093-X

21 January 2018

Molecular epidemiology of extended-spectrum beta-lactamases among Escherichia coli isolates collected in a Swedish hospital and its associated health care facilities from 2001 to 2006.

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1093-X

21 January 2018

Fecal carriage of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in patients and asymptomatic healthy individuals.

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1093-X

21 January 2018

Faecal carriage of extended-spectrum beta-lactamase-producing Escherichia coli: prevalence, risk factors and molecular epidemiology.

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1093-X

21 January 2018

Dramatic increase in prevalence of fecal carriage of extended-spectrum beta-lactamase-producing Enterobacteriaceae during nonoutbreak situations in Spain

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1093-X

21 January 2018

Community transmission of extended-spectrum beta-lactamase

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1093-X

21 January 2018

Surveillance of extended-spectrum beta-lactamases from clinical samples and faecal carriers in Barcelona, Spain.

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1093-X

21 January 2018

Risk-factors for acquisition of extended-spectrum beta-lactamase-producing Escherichia coli among hospitalised patients

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1093-X

21 January 2018

A multinational survey of risk factors for infection with extended-spectrum beta-lactamase-producing enterobacteriaceae in nonhospitalized patients.

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1093-X

21 January 2018

Fluoroquinolone prophylaxis in patients with neutropenia: a meta-analysis of randomized placebo-controlled trials

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1093-X

21 January 2018

Bacteremia due to extended-spectrum beta -lactamase-producing Escherichia coli in the CTX-M era: a new clinical challenge.

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1093-X

21 January 2018

Extended-spectrum beta-lactamases: a clinical update

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1093-X

21 January 2018

Emergence of fluoroquinolone-resistant Escherichia coli in fecal flora of cancer patients receiving norfloxacin prophylaxis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21052757

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing

1 reference

https://pubmed.ncbi.nlm.nih.gov/21052757

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epidemiology and successful control of a large outbreak due to Klebsiella pneumoniae producing extended-spectrum beta-lactamases.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21052757

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influx of extended-spectrum beta-lactamase-producing enterobacteriaceae into the hospital

1 reference

https://pubmed.ncbi.nlm.nih.gov/21052757

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A Change in the Epidemiology of Infections Due to Extended-Spectrum -Lactamase--Producing Organisms

1 reference

https://pubmed.ncbi.nlm.nih.gov/21052757

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevalence of fecal carriage of ESBL-producing Enterobacteriaceae in hospitalized and ambulatory patients during two non-outbreak periods

1 reference

https://pubmed.ncbi.nlm.nih.gov/21052757

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54376284&oldid=1790065950"